Votorantim S.A. has strategically diversified its portfolio by acquiring a 5.6% stake in Hypera, marking its entry into the healthcare sector, while continuing to focus on sustainability and robust financial performance.
Information on the Target
Votorantim S.A., a century-old investment group, has effectively navigated complex economic and geopolitical landscapes, reaffirming its commitment to resilient portfolio management in 2023. The organization generated a consolidated net revenue of R$ 48.5 billion, boasting an adjusted EBITDA of R$ 9.6 billion and a net income of R$ 1.8 billion. The results reflect a challenging cycle for metallic commodities but are bolstered by robust international performance, particularly within the cement sector following strategic acquisitions in North America and Spain.
Votorantim's operational efficiency and cost management strategies continue to enhance its overall portfolio resilience, leading to a strong balance sheet and fluid liquidity. The company's ongoing investment strategy aims to gradually transform its offerings to maximize future opportunities and secure its standing in the competitive market.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Brazil
Brazil's industrial sector has experienced considerable stability and growth, even amid global economic shifts. The country remains a significant player in the South American market, holding key position
Similar Deals
Wynnchurch → Charter Industries
2025
Votorantim
invested in
Hypera
in 2023
in a Other Private Equity deal
Disclosed details
Revenue: $10M
EBITDA: $2M
Net Income: $0M